2020. Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s62. DOI:https://doi.org/10.25251/skin.4.supp.61.